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Type 2 taste receptors (TAS2R) are G protein– coupled recep-
tors first described in the gustatory system, but have also been
shown to have extraoral localizations, including airway smooth
muscle (ASM) cells, in which TAS2R have been reported to
induce relaxation. TAS2R46 is an unexplored subtype that
responds to its highly specific agonist absinthin. Here, we first
demonstrate that, unlike other bitter-taste receptor agonists,
absinthin alone (1 M) in ASM cells does not induce Ca2 sig-
nals but reduces histamine-induced cytosolic Ca2 increases.
To investigate this mechanism, we introduced into ASM cells
aequorin-based Ca2 probes targeted to the cytosol, subplasma
membrane domain, or the mitochondrial matrix. We show that
absinthin reduces cytosolic histamine-induced Ca2 rises and
simultaneously increases Ca2 influx into mitochondria. We
found that this effect is inhibited by the potent human TAS2R46
(hTAS2R46) antagonist 3-hydroxydihydrocostunolide and is
no longer evident in hTAS2R46-silenced ASM cells, indicating
that it is hTAS2R46-dependent. Furthermore, these changes
were sensitive to the mitochondrial uncoupler carbonyl cyanide
p-(trifluoromethoxy)phenyl-hydrazone (FCCP); the mitochon-
drial calcium uniporter inhibitor KB-R7943 (carbamimido-
thioic acid); the cytoskeletal disrupter latrunculin; and an inhib-
itor of the exchange protein directly activated by cAMP (EPAC),
ESI-09. Similarly, the 2 agonist salbutamol also could induce
Ca2 shuttling from cytoplasm to mitochondria, suggesting that
this new mechanism might be generalizable. Moreover, forsko-
lin and an EPAC activator mimicked this effect in HeLa cells.
Our findings support the hypothesis that plasma membrane
receptors can positively regulate mitochondrial Ca2 uptake,
adding a further facet to the ability of cells to encode complex
Ca2 signals.
The existence of a family of bitter taste receptors was pre-
dicted over 20 years ago by Lush (1), and bitter taste receptor
(TAS2R) genes were first described in 2000 (2). In humans,
there are 25 subtypes of G protein– coupled receptors referred
to as hTAS2Rs4 (3–5) that vary in their selectivity toward bitter
compounds: Some subtypes recognize few chemically re-
stricted molecules, whereas some others respond to a wide
range of diverse ligands (6). In the same way, some bitter com-
pounds are known to be agonists for a single hTAS2R subtype,
whereas others are not selective (7).
Recently, hTAS2Rs have been reported to be expressed,
alongside tongue and palate epithelia, also on extraoral tissues
such as gut, genitourinary system, brain, immune cells, and res-
piratory system (8, 9). In airway smooth muscle (ASM), ago-
nists of the most-represented bitter taste receptor subtypes
(TAS2R10, 14, and 31) have been identified as novel pharma-
cological targets in obstructive pulmonary disease therapy (10 –
14). The expression of TAS2R and the bronchodilatory effect of
the agonists have been confirmed in mouse (15), guinea pig
(16), and human (12, 17, 18). Paradoxically, the bronchodilation
mechanism induced by activation of TAS2R10, 14, and 31 in
response to a contractile stimulus is mediated by an increase in
cytosolic calcium followed by membrane hyperpolarization
through large-conductance potassium channels (BKCa) (11,
16). Interestingly, it has been demonstrated that the level of
calcium increase is correlated to the level of receptor expres-
sion (11). More recently, Tan and Sanderson (19) have found
that agonists of TAS2R10, at concentrations required to dilate
mouse constricted airways, do not increase cytosolic calcium in
ASM, leading to the hypothesis that TAS2R agonists broncho-
dilate by inhibiting IP3 receptors and reducing calcium
sensitivity.
In the present manuscript, we focused on hTAS2R46, an
unexplored hTAS2R subtype receptor in ASM (13). An exten-
sive structure-function analysis of this subtype has been per-
formed (20) and sesquiterpene lactones, such as absinthin, rep-
resent selective agonists (6, 21).
We now report that absinthin per se does not induce Ca2
rises but significantly reduces the cytosolic Ca2 rise induced
by histamine in ASM. This reduction is not a consequence of
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reduced influx through the plasma membrane nor of a
decrease in Ca2 efflux from the endoplasmic reticulum, but
is a consequence of an increased Ca2 uptake by mitochon-
dria. Indeed, cytosolic Ca2 decreases and simultaneous
mitochondrial Ca2 increases were sensitive to the nonspe-
cific mitochondrial calcium uptake inhibitor carbamimido-
thioic acid (KB-R7943), to the mitochondrial uncoupler car-
bonyl cyanide p-trifluoromethoxyphenyl-hydrazone (FCCP), to
the selective hTAS2R46 inhibitor 3-hydroxydihydrocos-
tunolide (3HDC) (7), to the cytoskeletal disrupter latruncu-
lin, and to the EPAC antagonist ESI-09. Furthermore, the
effect of absinthin was no longer evident in hTAS2R46-
silenced cells. Our observation that absinthin, activating
hTAS2R46, modulates histamine-induced cytosol Ca2 rises
by potentiating mitochondrial Ca2 uptake shows that reg-
ulated mitochondrial Ca2 uptake may participate in the
encoding of Ca2 signals. We also provide data that this
ER-to-mitochondria shuttling may be a general feature of
Ca2 signaling as salbutamol, a 2-agonist, also reduces his-
tamine-induced Ca2 rises in the cytosol while simultane-
ously increasing mitochondrial calcium.
Results
Absinthin reduces histamine-induced Ca2 increases via
hTAS2R46
First, we evaluated the effect of absinthin on Ca2 rises in
ASM. Although other bitter taste receptor ligands have been
shown to increase cytosolic Ca2 (11), absinthin (10 M) was
unable to induce any Ca2 rise (n  7) (Fig. 1A).
We next evaluated the effect of absinthin on the Ca2-rise
induced by one of the most potent bronchoconstrictors, hista-
mine (10 M). As shown in Fig. 1, A and B, histamine induced a
rapid Ca2 rise, as determined by Fura-2. The simultaneous
co-addition of absinthin, surprisingly, led to a significantly
lower histamine-induced Ca2 peak. This effect was evident
when pooling the data together but was just as evident at the
single cell level in fluorescence microscopy (data not shown).
Because histamine-induced Ca2 rises are the result of an ini-
tial Ca2 release from intracellular stores and a secondary Ca2
entry, we performed experiments in a Ca2-free extracellular
buffer to dissect the two components. As demonstrated in Fig.
1B, histamine induced a cytosolic Ca2 rise in this condition,
which was of lower amplitude compared with the previous con-
dition. Yet, absinthin was still able to significantly reduce the
effect of histamine.
Absinthin is reported to bind different bitter taste receptor
subtypes, although it is generally thought to act mainly on
hTAS2R46 (6). We therefore evaluated whether hTAS2R46
was present in our cellular model. Indeed, RT-PCR experi-
ments showed that mRNA coding for this subtype was present
in ASM, although at lower levels compared with human bron-
chial muscle and human epithelial tongue (Fig. S1A). This was
confirmed also by Western blotting, immunofluorescence, and
immunohistochemistry of ASM with specific antibodies (Fig.
S1, B–F). We next evaluated whether 3HDC, a potent antago-
nist of hTAS2R46 (7), was able to revert the effect of absinthin
on histamine-induced Ca2 rises. As shown in Fig. 1C, 3HDC
dose-dependently reverted the effect of absinthin, with concen-
trations of 10 M abolishing completely the effect of the agonist.
To further determine the specificity of this effect, we performed
experiments in HeLa cells that are devoid of hTAS2R46 (Fig.
S1B) but that have phospholipase C-coupled histamine recep-
tors (22). As shown in Fig. 1D, absinthin was unable to affect
histamine-induced Ca2 rises in HeLa cells, even at high con-
centrations (100 M). Last, we made use of shRNA to confirm
that it was indeed hTAS2R46 mediating the absinthin response.
The use of shRNA led to a decrease of the mRNA encoding for
the receptor in ASM cells of 90  2.5% (as determined by RT-
PCR and Western blotting) compared with control ASM cells
(Fig. S1, A and B). In cells with a significantly reduced level of
hTAS2R46, absinthin was unable to reduce histamine-induced
cytosolic Ca2 rises (Fig. 1E).
These data demonstrated that absinthin reduced cytosolic
Ca2-rises induced by histamine by a receptor-specific mech-
anism mediated by hTAS2R46. This effect occurs rapidly and
appears to affect the Ca2-release component of the rise, given
that it is apparent also in Ca2-free conditions.
Absinthin does not affect subplasmallemal Ca2
To evaluate whether the Ca2-entry component of the
histamine-induced Ca2 rise was also affected, we decided to
use aequorin-based probes that can be targeted selectively to
subcellular compartments. At first, we confirmed the effect
of absinthin on histamine-induced Ca2 rises using a non-
targeted cytosolic aequorin (cytAEQ) (23). In accordance
with what was observed with Fura-2, absinthin dampened
the peak of the Ca2 rise in a significant manner (Fig. 2A).
We next decided to evaluate whether Ca2 entry was
affected by using an aequorin probe directed to the sub-
plasma membrane compartment (pmAEQ) (24, 25). In this
instance, histamine-induced Ca2 entry was not affected by
the co-addition of absinthin (Fig. 2B).
To further confirm that Ca2 entry was not involved, we
performed a store depletion experiment investigating cytosolic
calcium via Fura-2. Stores were depleted with tBHQ (50 M) in
a calcium-free solution and calcium was re-added after 5 min in
the presence or absence of absinthin. As shown in Fig. S2, absin-
thin was unable to affect the extent of store-operated Ca2
entry. These data therefore suggest that absinthin targets selec-
tively the intracellular store component of histamine-induced
Ca2 rises.
Absinthin controls mitochondrial calcium buffering
To reconcile the above, partly contradictory observations
on absinthin (i.e. a decreased cytosolic calcium rise together
with an unchanged Ca2 entry), we inquired whether mito-
chondrial Ca2 in response to histamine would change in
accord to cytosolic Ca2. If absinthin dampens Ca2 release
via IP3R modulation or via IP3 production, it would be
expected that mitochondrial Ca2 uptake in the presence of
absinthin after stimulation with histamine should be low-
ered as well. To test this hypothesis, we used an aequorin
probe that targets selectively the mitochondrial matrix
(mitAEQ) (24, 26). As shown in Fig. 3A, stimulation of cells
with histamine provoked an increase in mitochondrial Ca2
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(27) whereas the addition of absinthin alone had no effect. In
striking contrast to the effect on cytosolic Ca2, the hista-
mine-induced mitochondrial Ca2 rise in the presence of
absinthin was significantly greater compared with histamine
alone (Fig. 3A).
The above data appeared to suggest that the reduced cyto-
solic Ca2 rise is paralleled by a paradoxical increase in mito-
chondrial Ca2 uptake, i.e. it would suggest that histamine-
induced Ca2 release is unaffected by absinthin, but the
Ca2 is channeled to the mitochondria and not to the cyto-
sol. If this were the case, it would be expected that disrupting
the mitochondrial membrane potential, which drives Ca2
uptake by the mitochondrial calcium uniporter (MCU), with
FCCP, and thereby not permitting mitochondrial Ca2
Figure 1. Absinthin reduces histamine-induced Ca2 transients. Data are illustrated in representative traces as well as in scatter plots expressing the
mean  S.D. of maximum peak of cytosolic Ca2 release. A and B, fura-2–loaded ASM cells were stimulated with histamine (Hist) 10 M and absinthin
(Abs) 10 M alone or combined, in the presence of calcium (A, Student’s t test, t(12)  2.57, tcr  2.17; °, p  0.024) or in Ca
2-free conditions (EGTA 100
M) (B, Welch’s t test, t(9.13)  2.39, tcr  2.26; *, p  0.040). C, ASM cells stimulated with histamine (Hist, 10 M), absinthin (Abs, 10 M) and increasing
concentrations of receptor antagonist 3HDC (0.1, 1, 10 M). A linear regression confirmed a statistically significant increasing trend in cytosolic free
calcium response determined by 3HDC (F(1,20)  16.45, Fcr  4.35; °°°, p  6.1710
4), whereas no significant difference was found between Hist and
3HDC (10 M)HistAbs (Student’s t test, t(10)  0.13, tcr  2.23, p  0.90). D, cytosolic calcium release measurement in nonexpressing hTAS2R46 HeLa
cells stimulated with histamine (Hist, 100 M) and absinthin at the indicated concentrations. No significant relation emerged by linearly regressing
cytosolic free calcium against increasing doses of Abs (F(1,16)  0.009, Fcr  4.49, p  0.93). E, ASM cells infected with LVs carrying shRNA-hTAS2R46 and
treated as in A. Absinthin modulation of histamine-induced calcium release was analyzed in the two cellular models through a two-way ANOVA. The
presence of a statistically significant interaction between the two factors (F(1,14)  11.40, Fcr  4.6, p  0.0045) reflects the simple main effects for which
the significant decrease in cytosolic calcium following absinthin addition observed in ASM (°°°, p  7.01104) completely vanished when moving to
ASM shRNA-hTAS2R46 model (p  0.62).
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uptake, should block the Ca2 increase in mitochondria
induced by histamine in the presence of absinthin and simul-
taneously restore the histamine-Ca2 rise in the cytosol.
Indeed, when FCCP was used, this resulted in a significantly
reduced Ca2 rise in mitochondria (Fig. 3A) and an increase
in the cytosolic Ca2 rise that was equivalent, if not greater,
to histamine alone (Fig. 3B). Subplasmalemmal Ca2, on the
contrary, was unchanged, suggesting that the extent of mito-
chondrial uptake does not influence Ca2 entry via the
plasma membrane (Fig. 3C).
Ca2-uptake in mitochondria is mediated by MCU, a protein
complex whose main components have been recently identified
(28, 29). In the presence of KB-R7943, a nonspecific inhibitor of
the uniporter (30), the effect of absinthin on histamine-induced
mitochondrial Ca2 rises was abolished (Fig. 3A), as was the
effect on cytosolic Ca2 (Fig. 3B), whereas again no difference
was perceivable in subplasmalemmal Ca2 (Fig. 3C). FCCP or
KB-R7943 alone did not affect basal Ca2 or Ca2 signals
induced by histamine (Fig. S3, A–D).
An intact cytoskeletal structure is necessary for the action of
absinthin
The above data would suggest that absinthin signals to the
mitochondria to increase the uptake of the Ca2 released from
the endoplasmic reticulum (ER). If this were the case, it could be
expected that disrupting the ER-mitochondria juxtapositions
would, at least in part, abolish the effect of absinthin. To this
extent, we pre-incubated cells with latrunculin, a natural com-
pound that disrupts the actin cytoskeleton thereby uncoupling
organelle cross talk (31). As observed in Fig. 4A, in cells pre-
incubated with latrunculin, the cytosolic Ca2 rises induced by
histamine were similar in the presence or absence of absinthin
in the cytosol (Fig. 4A; see Fig. 1 for traces in the absence of
absinthin) under the plasma membrane (Fig. 4B) and in mito-
chondria (Fig. 4C).
Neither a change in mitochondrial membrane potential nor a
change in ATP/ADP ratio occurs upon absinthin addition
We reasoned that absinthin might modify the mitochon-
drial potential, and this might then be responsible for the
increased mitochondrial accumulation. To test for this, we
used the JC-1 probe, but found no difference of mitochon-
drial membrane potential in the presence or absence of
absinthin (Fig. S4A).
Next, we investigated whether an increase in mitochondrial
Ca2 during this time frame could significantly increase cyto-
solic ATP levels. If this were the case, it could be expected that
extruding mechanisms could be more efficient and it could
Figure 2. Absinthin does not affect subplasma membrane histamine-induced calcium transients. A, cytosolic Ca2 variations in ASM cells infected with
LV expressing cytAEQ after treatment with histamine (Hist, 10 M) and/or absinthin (Abs, 10 M) alone, or in combination. One-way ANOVA (F(2,17)  22.04,
Fcr  3.59, p  1.910
5) with Dunnett’s multiple comparison test versus Hist, °°°, p  1.6105; **, p  0.0016. B, subplasma membrane Ca2 variations in ASM
cells infected with LV expressing pmAEQ. Kruskal-Wallis H test (H(3)  12.94, Hcr  7.81, p  0.0048) with Dunn’s multiple comparison test: Hist versus Ca
2 2 mM
°, p  0.012; HistAbs versus Ca2 2 mM *, p  0.015; HistAbs versus Hist p  0.94. Data are illustrated in representative traces as well as in scatter plots
expressing the mean  S.D. of maximum peak of Ca2 release.
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account for part of the drop in cytosolic Ca2. As shown in Fig.
S4B, absinthin, unlike the positive control FCCP, was unable to
modify significantly ATP to ADP ratios.
2-adrenoreceptor activation mimics the effects of hTAS2R46
activation
To evaluate whether other plasma membrane receptor ago-
nists were able to trigger a similar mechanism, we investigated
the Ca2 response of histamine in the presence of a 2 agonist,
the most widely used bronchodilators in asthma and chronic
obstructive pulmonary disease. As expected, salbutamol (10
M) lowered the Ca2 rise induced by histamine (Fig. 5A). This
has been reported previously and has been attributed to a num-
ber of cAMP- and PKA-dependent effects, including IP3 recep-
tor modulation (32). Surprisingly, though, histamine-induced
mitochondrial Ca2 increased significantly also in the presence
of salbutamol (Fig. 5A).
cAMP or EPAC modulation modifies cytosolic and
mitochondrial histamine–induced Ca2 transients in HeLa
and ASM cells
Given that 2 receptors are coupled to cAMP formation, we
attempted to reproduce the effect with forskolin (10 M). In the
presence of forskolin, cytosolic histamine–induced Ca2 rises
were significantly blunted (Fig. 5A). When evaluating mitochon-
drial calcium, the concentration was also blunted, although not to
the same extent (Fig. 5A). Yet, the effect of a strong cAMP produc-
tion induced by forskolin prevented firm conclusions.
From the data on forskolin and, more importantly on salbu-
tamol, it would appear that a cAMP-dependent pathway may
Figure 3. Absinthin potentiates mitochondrial histamine-induced calcium transients. A, mitochondrial calcium concentrations in ASM cells
infected with LV expressing mitAEQ after treatment with histamine (Hist, 10 M), absinthin (Abs, 10 M), KB-R7943 (10 M), FCCP (10 M). One-way
ANOVA (F(3,24)  5.02, Fcr  3.00, p  0.0076) with Dunnett’s multiple comparison test versus HistAbs,
, p  0.0022; *, p  0.038; °, p  0.033. B,
cytosolic Ca2 changes using identical conditions to (A) but determined by Fura-2. One-way ANOVA (F(3,20)  6.23, Fcr  3.10, p  0.0037) with Tukey’s
multiple comparison test: Hist versus HistAbs , p  0.027; KBHistAbs versus HistAbs *, p  0.039; FCCPHistAbs versus HistAbs °°, p 
0.0023; KBHistAbs versus Hist p  0.99; FCCPHistAbs versus Hist p  0.65. C, subplasma membrane Ca2 variations using identical conditions to
(A). Kruskal-Wallis H test (H(5)  16.42, Hcr  11.07, p  0.0057) with Dunn’s multiple comparison test: all versus Ca
2 2 mM, , p  0.0059; *, p  0.016;
°°, p  0.008; , p  0.027. All the comparisons involving KBHistAbs or FCCPHistAbs versus both Hist and HistAbs did not show statistically
significant differences (p  0.82). Data are illustrated in representative traces as well as in scatter plots expressing the mean  S.D. of maximum peak
of Ca2 release.
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control ER to mitochondria Ca2 shuttling. It has been recently
reported that Epac1 is localized on the mitochondrial inner
membrane and matrix (and may control MCU activity) (33, 34).
To test whether the actions of absinthin were mediated by
EPAC, we performed identical experiments to those described
using the EPAC-specific inhibitor ESI-09. As shown in Fig. 5B,
ESI-09 was able to counteract the effect of absinthin on both
cytosolic and mitochondrial Ca2.
We next proceeded to investigate cAMP rises upon hista-
mine, histamine/absinthin, and forskolin in ASM cells using a
cytosolic FRET probe. As expected, forskolin induced a rise in
cytosolic cAMP in the same time frame as the regulation of
histamine-induced Ca2 rises. On the contrary, however,
absinthin did not appear to have any direct effect on cAMP
levels in this time frame (Fig. S5).
Last, we investigated whether the same effect was observ-
able in another cell type, HeLa. As shown in Fig. 5C both
forskolin and the EPAC activator 8-pCPT-2-O-Me-cAMP
were able to reduce cytosolic Ca2 rises induced by hista-
mine while increasing mitochondrial Ca2 rises, confirming
that the phenomenon is likely to be present in other cell
types.
Figure 4. Effect of actin filament disruption on absinthin modulation of histamine-induced Ca2 transients. A, fura-2–loaded ASM cells were stimulated
with histamine (Hist) 10 M with or without absinthin (Abs) 10 M in the presence of latrunculin A (10 M for 1 h). Student’s t test, t(6)  0.44, tcr  2.45, p  0.68.
B, subplasma membrane Ca2 variations using identical conditions to (A). One-way ANOVA (F(2,10)  34.06, Fcr  4.10, p  3.4410
5) with Tukey’s multiple
comparison test: Hist versus Ca2 2 mM ****, p  5.66105; HistAbs versus Ca2 2 mM ***, p  0.0004; Hist versus HistAbs p  0.19. C, mitochondrial calcium
concentrations using identical conditions to (A). Student’s t test, t(9)  0.067, tcr  2.26, p  0.95. Data are illustrated in representative traces as well as in scatter
plots expressing the mean  S.D. of maximum peak of Ca2 release.
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Discussion
In the present report we show that absinthin, via hTAS2R46,
inhibits histamine-induced cytosolic Ca2 rises in ASM cells
via a positive modulation of mitochondrial Ca2 uptake possi-
bly through the regulation of EPAC. The evidence that this
occurs via a specific plasma membrane receptor is given by (i)
the relative specificity of absinthin; (ii) the sensitivity of the
effect to the specific receptor inhibitor 3HDC; and (iii) the
inability of absinthin to elicit the same effect in HeLa cells,
where hTAS2R46 is not expressed and in hTAS2R46-silenced
ASM cells. The evidence that mitochondrial uptake is the
mechanism by which this occurs is given by (i) the significant
increase in mitochondrial calcium paralleled by the decrease in
cytosolic calcium of the [Ca2]i-histamine induced in the pres-
ence of absinthin; (ii) the abolition of the effect in the presence
of the mitochondrial uncoupler FCCP; and (iii) the abolition of
the effect in the presence of the mitochondrial Ca2 uptake
inhibitor KB-R7943, the similarity in subplasmalemmal cal-
cium, and in tBHQ-triggered store-operated Ca2 entry, sug-
gesting that store emptying is similar in the presence or absence
of absinthin. The use of FCCP leads to a cell-wide decrease in
ATP to ADP ratio and this is a limitation of our data as it might
have confounded partly the results (given that Ca2 extrusion
and reuptake should be hampered), but we believe that overall
our data are consistent across experiments.
The evidence that EPAC is most likely the mediator of
this effect is given by (i) the ability of salbutamol to elicit
identical effects; (ii) the fact that forskolin is in part able to
mimic the effect; more importantly (iii) the ability of ESI-09
to abolish the effects of absinthin; and (iv) the ability of the
EPAC activator 8-pCPT-2-O-Me-cAMP to increase mito-
chondrial Ca2 in HeLa cells.
Figure 5. cAMP and EPAC modulation on cytosolic and mitochondrial calcium transients. Values of cytosolic calcium peaks are plotted on left Y axes, and
the mitochondrial ones are plotted on right Y axes. Because the two continuous (dependent) variables [Ca2]cyt and [Ca
2]mit are not directly comparable,
cytosolic and mitochondrial data sets were analyzed independently. In any case, data are illustrated in scatter plots expressing the mean  S.D. of maximum
peak of Ca2 release. A, cytosolic and mitochondrial calcium concentrations in ASM cells infected with LV expressing cytAEQ or mitAEQ after treatment with
histamine (Hist, 10 M) alone or with salbutamol (10 M), or forskolin (10 M). One-way ANOVA (cytosol F(2,18)  10.62, Fcr  3.55, p  8.9910
4; mitochondria
F(2,13)  9.85, Fcr  3.81, p  0.0025) with Dunnett’s multiple comparison test versus respective Hist, °°, p  0.0017; **, p  0.0080;
, p  0.025. B, cytosolic and
mitochondrial calcium concentrations in ASM cells infected with LV expressing cytAEQ or mitAEQ after treatment with histamine (Hist, 10 M) with or without
absinthin (Abs, 10 M) and a pan-EPAC inhibitor (ESI-09, 10 M). One-way ANOVA (cytosol F(2,33)  15.61, Fcr  3.28, p  1.6910
5; mitochondria F(2,13)  6.48,
Fcr  3.81, p  0.011) with Dunnett’s multiple comparison test versus respective HistAbs, °, p  0.019; ****, p  1.1310
5; , p  0.016; , p  0.0098. C,
cytosolic and mitochondrial calcium concentration in HeLa cells infected with LV expressing cytAEQ or mitAEQ after treatment with histamine (Hist, 100 M),
alone or with forskolin (20 M), or 8-pCPT-2-O-Me-cAMP (10 M). Cytosol: One-way ANOVA, F(2,23)  10.65, Fcr  3.42, p  5.310
4; with Dunnett’s multiple
comparison test versus Hist, °°°, p  0.0003; *, p  0.040. Mitochondria: Kruskal-Wallis H test (H(2)  9.87, Hcr  5.99, p  0.0072) with Dunn’s multiple comparison
test, , p  0.012; , p  0.0079; both versus Hist.
hTAS2R46 regulates mitochondrial calcium buffering
12478 J. Biol. Chem. (2019) 294(33) 12472–12482
We believe this is the first report of a positive modulation of
mitochondrial Ca2 uptake by plasma membrane G protein–
coupled receptors, although it had been long known that recep-
tor agonists are able to increase mitochondrial Ca2 (35) and
that postulations on the role of mitochondrial uptake in shap-
ing cytosolic signals date back in time (36). Indeed, one of the
most striking characteristics of this modulation is the speedi-
ness by which it occurs, as simultaneous activation of histamine
receptors and TAS2R46/2-adrenoreceptors is sufficient to
elicit an effect. When superimposing traces, the mitochondrial
Ca2 transient lags just a few seconds behind the cytosolic
transient.
Although it is possible that TAS2R46 activation directly
affects the signaling of histamine receptors (for example
reducing the Gq coupling), this would explain the reduction
in cytosolic Ca2 but would be unable to explain the increase
in mitochondrial Ca2 and the absence of a difference in
subplasmalemmal Ca2.
It is thought that microdomains of high Ca2 at the mouth of
IP3 receptors are necessary in ER-mitochondria juxtapositions
to drive Ca2 uptake into mitochondria. Ca2 flows through
the voltage-dependent anion channel (VDAC), located on the
mitochondrial outer membrane, and then through the mito-
chondrial Ca2 uniporter located on the inner membrane.
Importantly, a Ca2 increase in mitochondria has physiological
repercussions, including an increased activity of pivotal oxida-
tive phosphorylation enzymes (37) and a protection from
excessive Ca2 surges. It has been recently suggested that
Epac1 favors Ca2 exchange between the ER and the mitochon-
drion in heart via the VDAC/GRP75/IP3R1 complex (34), and it
is likely that a similar mechanism occurs in smooth muscle
cells.
In this respect, it can be imagined that TAS2R46 activa-
tion not only controls histamine-induced Ca2 contractions
but also provides an energetic boost to smooth muscle cells
and protects them. Indeed, genetic ablation or inhibition of
EPAC1 in cardiac myocytes has been shown as protective in
myocardial ischemia/reperfusion injury (33). In this respect,
it is interesting to note that a TAS2R ligand has been recently
reported to decrease mitochondrial membrane potential and
increase mitochondrial reactive oxygen species and mito-
chondrial fragmentation (38). Yet, when we tested mem-
brane potential changes with absinthin, we were unable to
detect any. Furthermore, an energetic boost stimulated by
Ca2 (39) should be expected to increase ATP to ADP ratio
in the cytosol (which in turn could also render Ca2 pumps
more efficient and partly explain the cytosolic drop). Yet, by
using a PercevalHR probe, which measures ATP/ADP ratios
(see supporting Experimental procedures), we were unable
to detect any significant changes in the time frame of treat-
ment. The possibility that ATP/ADP ratios were below our
threshold of detection is possible.
Although we have not investigated the molecular mechanism
of action of the Ca2 shuttling, a few hypotheses can be made.
First, TAS2R46 could be controlling ER-mitochondria juxtapo-
sitions, a mechanism that has been postulated by others to
modify mitochondrial uptake (40 –42). In this respect, when we
performed time-lapse microscopy using MitoTracker, we were
unable to see any significant movements of mitochondria dur-
ing the 100 s post treatment (data not shown). Alternatively, a
posttranslational event could occur either on VDAC/MCU or
one of its regulatory proteins (e.g. MICU, mitofusin). VDAC is
known to increase its conductance for Ca2 in its closed con-
formation (43) and such an event could explain the increased
amount of Ca2 entering the mitochondria. A regulation of
MCU is also possible, although its localization on the inner
membrane would create a topological problem, it should be
noticed that the regulation is rapid, as simultaneous addition of
histamine and absinthin/salbutamol is sufficient to unmask the
effect.
Independently of the mechanism by which this occurs, we
believe we have shown that activation of TAS2R46 leads to a
redirection of IP3R Ca2 efflux from the cytosol to the mito-
chondria (i.e. from cytosolic modulation to mitochondrial reg-
ulation), and this is most likely mediated by EPAC, providing a
further mechanism by which Ca2 signals can be encoded by
cells.
A limitation of our study was our inability to detect cAMP
rises upon absinthin addition. This may suggest that our
FRET system does not have sufficient spatial resolution to
detect discrete microdomains of cAMP (44), that the size of
the cAMP increase is below the limit of detection, or that
cAMP increases in mitochondria and not in the cytosol. This
last hypothesis would be supported by a recent paper that
showed that aldosterone increases selectively the activity of
the soluble adenylyl cyclase in the mitochondria and that the
inhibition of EPAC reduced mitochondrial Ca2 uptake, in a
similar fashion to what was observed in the present contri-
bution (45). It would be unlikely that EPAC, instead, is acti-
vated in a cAMP-independent fashion as this has never been
reported previously. What links TAS2R46 to EPAC is there-
fore so far elusive.
It is generally accepted that high concentrations of cAMP,
via PKA, are able to potentiate IP3-induced Ca2 release via
phosphorylation of the IP3 receptor (Ref. 46 and references
therein). Our study does not contradict such notion as we have
always used maximal concentrations of histamine whereas sub-
maximal concentrations of phospholipase C-coupled receptor
agonists are required to see this potentiation. Furthermore, we
could not detect significant cAMP rises in the cytosol and it is
therefore unlikely that a cytosolic PKA is activated in our
conditions.
Recently, Dale et al. (47) have shown that in human bronchial
airway smooth muscle cells, histamine-induced cytosolic Ca2
rises may be blunted by isoproterenol and proposed a model by
which compartmentalized cAMP rises negatively feedback via
PKA to the histamine receptor. In our study, we were unable to
determine the absolute level of Ca2 released and therefore
cannot rule out that IP3 formation from histamine activation is
reduced upon TAS2R46 activation. It is therefore possible that
the two events occur simultaneously. Interestingly, Dale et al.
(47) are able to observe an effect on histamine but not on other
Ca2-mobilizing agents, suggesting a certain degree of specific-
ity. Preliminary data from our lab also shows that the mito-
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chondrial uptake increase is not evident when carbachol or bra-
dykinin are used to induce Ca2 mobilization.5
It should be noted that we used a single Ca2 indicator for
mitochondria (aequorin). Although it is unlikely that this may
have resulted in artifacts, given also the consistency of results
across protocols, this limitation should be acknowledged.
To describe this new Ca2-signaling pathway, we made use
of fluorescent imaging, a common technique in the field, cou-
pled to aequorin-targeted probes and luminometry, which are
less frequently employed. For these reasons, it might not be
surprising that we have also unraveled a new mechanism that




A voucher specimen of the Pancalieri chemotype of Artemi-
sia absinthium is kept in Novara laboratories. 1300 g of leaves
and flowers, powdered, were extracted with acetone (3  7.5
liters) in a vertical percolator at room temperature, affording
97 g (7.5%) of a dark green syrup. The acetonic extract was
dissolved into the minimal amount of acetone at 45 °C and then
97 g silica gel was added (ratio extract/silica 1:1); finally the
suspension was evaporated. The powder obtained in this way
was stratified on a layer of 485 g of aluminum oxide (ratio
extract/alumina 1:5) packed with petroleum ether (40:60) and
protected on its surface by a filter paper in a sintered filtration
funnel (9  15 cm) with side arm for vacuum. The dissolved
extract was purified with petroleum ether– ethyl acetate gradi-
ent from 90:10 to 60:40 (100 ml fraction) by vacuum chroma-
tography. Fractions eluted with petroleum ether– ethyl acetate
40:60 afforded 8.7 g of pure absinthin (0.66%) whose structure
elucidation and purity were confirmed from 1H NMR (Fig. S6)
according to Beauhaire et al. (48).
Cell culture
Human primary lung ASM cells were obtained from ATCC
(catalog PCS-130-010). ASM cells were maintained in Vascular
Cell Basal Medium (ATCC, catalog PCS-100-030) supple-
mented with 5% heat-inactivated fetal bovine serum (FBS), 5%
L-glutamine, 0.5% antibiotic-antimycotic (all Thermo Fisher), 5
ng/ml of basic fibroblasts growth factor and 5 ng/ml epidermal
growth factor (ImmunoTools), 50 g/ml of ascorbic acid, 10
ng/ml of insulin (Sigma-Aldrich).
HEK293T and HeLa cells were maintained in DMEM (Sig-
ma-Aldrich) supplemented with 10% FBS, 1% L-glutamine, and
1% antibiotic-antimycotic.
Lentiviral vectors (LVs) for hTAS2R46 shRNA
hTAS2R46 was silenced by lentiviral infection. Several lenti-
viral constructs targeting hTAS2R46 were obtained from TRC-
Hs1.0 library (Dharmacon). Third-generation LVs were pro-
duced co-transfecting HEK293T packaging cells with plasmids
pMDLg/pRRE, pMD2.VSVG, pRSV-Rev and transfer construct
using the Lipofectamine (Life Technologies) transfection
method and concentrated by PEG precipitation, as described
previously (24). ASM cells were infected with the two LV-shRNAs
(TCRN0000014110 and TCRN0000014112) together (referred as
to shRNA-hTAS2R46) and the silencing was assessed by real
time PCR and Western blotting as described in the supporting
information.
Calcium imaging
5  104 ASM or HeLa cells were plated on glass coverslips
coated with poly-L-lysine (Sigma). The next day cells were
loaded with Fura-2AM (5 M) and pluronic acid (0.005%) (all
Thermo Fisher) in Vascular Cell Basal Medium for 30 min at
room temperature in the dark. After washing and de-esterifica-
tion (20 min) the coverslip was mounted in a chamber equipped
with a thermostat and placed on the stage of a Leica epifluores-
cence microscope equipped with a S Fluor 40/1.3 objective.
Cells were alternatively excited at 340/380 nm by the mono-
chromator Polichrome V (Till Photonics, Munich, Germany)
and the fluorescent signal was collected by a CCD camera
(Hamamatsu, Japan) through band-pass 510 nm filter; the
experiments were controlled and images analyzed with Meta-
Fluor (Molecular Devices, Sunnyvale, CA) software. The cells
were treated with the following stimuli alone or combined: his-
tamine 10 M (Sigma-Aldrich); absinthin 10 M; KB-R7943
(Sigma-Aldrich) 10 M; FCCP (Sigma-Aldrich); 3HDC (7) 0.1,
1, and 10 M; salbutamol 10 M (Sigma-Aldrich); and forskolin
10 M (Sigma-Aldrich). To quantify the differences in the peaks
of Ca2 transients the ratio values were normalized using the
formula (Fo  Fc )/Fo (referred to as normalized Fura-2 ratio;
norm. ratio). To evaluate absinthin effect in calcium-free con-
ditions, cytosolic Ca2 was monitored upon depletion of exter-
nal Ca2 (by EGTA 100 M). Actin filament disrupter latrun-
culin A was used at 10 M (Sigma-Aldrich).
Aequorin-based Ca2 measurements
We have monitored fluctuations of Ca2 concentrations in
the cytosol, in the domains adjacent to the plasma membrane,
and in the mitochondrial matrix. To this end, we have used
third-generation LVs to infect cells with the constructs encod-
ing the native aequorin (cytAEQ-LV) or aequorin N-terminally
linked to the synaptic-associated protein 25 (SNAP-25) (pLV-
pmAEQ-LV) or to the COXVIII cleavable leader sequence
(mitAEQ-LV). Generation of the plasmids was reported else-
where (24). Lentiviral particles were produced by Lipo-
fectamine transfection of HEK293T cells and concentrated by
PEG precipitation (24). To monitor Ca2 levels in different cel-
lular compartments we used a custom built aequorinometer
(CAIRN Research). ASM and HeLa cells were plated on 12 mm
coverslips in a 24-well plate at a density 2  104 cells/well. After
24 h, cells were infected with cytAEQ-, pmAEQ-, or mitAEQ-
expressing lentiviral particles. After 48 –72 h, cells were washed
with Krebs-Ringer buffer (KRB; 135 mM NaCl, 5 mM KCl, 0.4
mM KH2PO4, 1 mM MgSO4, 5.5 mM glucose, 20 mM HEPES, pH
7.2) and reconstituted with native coelenterazine (catalog
C2230, Sigma-Aldrich) at 37 °C, in dark for 30 min. Then, cov-
erslips were transferred into perfusion chamber of the aequori-
nometer. To assess subplasma membrane calcium, cells were
firstly perfused with KRB containing 100 M EGTA for 100 s for5 M. Talmon and L. Fresu, unpublished results.
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baseline recording, and then the perfusion solution was
switched to KRB-EGTA 100 M supplemented with 20 M
tBHQ (Sigma-Aldrich). After 120 s cells were perfused with
KRB-Ca2 2 mM in presence of the stimuli of interest alone or
combined: histamine 10 M, absinthin 10 M, salbutamol 10
M, KB-R7943 10 M, FCCP 10 M, forskolin 10 M. To assess
calcium changes in the cytosol or mitochondria, cells were per-
fused with KRB containing Ca2 2 mM for 100 s and then with
KRB-Ca2 added by the already mentioned stimuli. HeLa cells
were also challenged with histamine in presence of 8-pCPT-2-
O-Me-cAMP (10 M; Sigma-Aldrich) a cAMP analogue that
specifically activates EPAC (49). For quantification of Ca2
concentration, at the end of each experiment cells were per-
fused with distilled water containing 0.1% Triton and 50 mM
Ca2 to discharge the remaining aequorin pool. Emitted light
was converted in Ca2 concentrations offline using a previously
described algorithm (50). All measurements were carried out at
37 °C.
Statistical analysis
Data are presented as mean  S.D. of n independent exper-
iments. All samples were first tested for normality (Shapiro-
Wilk test) and for homogeneity of variance (Levene’s test).
When possible, statistical significance was assessed by para-
metric tests, i.e. linear regression and t test or one-way analysis
of variance (ANOVA) (followed by Tukey’s or Dunnett’s post
hoc test) in the case of continuous and categorical independent
variables, respectively. Otherwise, nonparametric alternatives
were used, as detailed in the figure legends. Unless otherwise
specified, all statistical tests were between unpaired samples,
two-tailed, and a p value  0.05 was considered statistically
significant.
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